Neon Therapeutics, Inc.
(NASDAQ : NTGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-0.09%282.031.4%$840.94m
AMGNAmgen, Inc.
-0.14%220.551.3%$515.03m
CELGCelgene Corp.
-0.24%109.761.3%$465.66m
GILDGilead Sciences, Inc.
-0.97%64.441.0%$396.47m
VRTXVertex Pharmaceuticals, Inc.
-0.67%208.391.9%$311.78m
ILMNIllumina, Inc.
-0.24%305.263.5%$310.58m
REGNRegeneron Pharmaceuticals, Inc.
-1.23%340.622.6%$264.38m
EXASEXACT Sciences Corp.
0.02%82.0724.0%$209.83m
ALXNAlexion Pharmaceuticals, Inc.
-0.31%108.042.0%$179.25m
SGENSeattle Genetics, Inc.
1.09%116.006.1%$138.45m
BMRNBioMarin Pharmaceutical, Inc.
0.73%75.594.3%$124.55m
SRPTSarepta Therapeutics, Inc.
0.41%97.8614.6%$115.85m
AAgilent Technologies, Inc.
-0.15%78.141.6%$101.20m
NBIXNeurocrine Biosciences, Inc.
1.84%115.135.0%$92.07m
BGNEBeiGene Ltd.
-2.87%192.562.1%$86.09m

Company Profile

Neon Therapeutics, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.